Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $25.00 at Oppenheimer
Tyra Biosciences (NASDAQ:TYRA – Free Report) had its target price decreased by Oppenheimer from $28.00 to $25.00 in a report published on Thursday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the stock. Several other research firms also recently commented on TYRA. HC Wainwright reiterated a buy rating and issued a $23.00 price […]
More Stories
QuickLogic (NASDAQ:QUIK) Posts Earnings Results, Misses Expectations By $0.01 EPS
QuickLogic (NASDAQ:QUIK – Get Free Report) issued its quarterly earnings data on Monday. The semiconductor company reported ($0.06) earnings per...
Braemar Hotels & Resorts (NYSE:BHR) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Braemar Hotels & Resorts (NYSE:BHR – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.02)...
iShares iBonds Dec 2054 Term Treasury ETF (NASDAQ:IBGK) Short Interest Up 275.0% in October
iShares iBonds Dec 2054 Term Treasury ETF (NASDAQ:IBGK – Get Free Report) was the recipient of a large increase in...
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update
Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) was the target of a large decrease in short interest in October....
Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Up 278.4% in October
Haoxi Health Technology Limited (NASDAQ:HAO – Get Free Report) was the recipient of a significant growth in short interest during...
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN) Stock Price Down 1.7% – Here’s Why
iShares JPX-Nikkei 400 ETF (NYSEARCA:JPXN – Get Free Report)’s stock price dropped 1.7% on Tuesday . The company traded as...